State Of Wyoming Kaleido Biosciences, Inc. Transaction History

State Of Wyoming

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$1.3 - $2.7 $2,906 - $6,037	-2,236 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$2.39 - $6.02 $329 - $830	138 Added 6.58%	2,236 $5,000
Q3 2021 Feb 11, 2022	SELL	$5.36 - $7.99 $75 - $111	-14 Reduced 0.66%	2,098 $11,000
Q2 2021 Feb 11, 2022	BUY	$5.82 - $8.72 $12,291 - $18,416	2,112 New	2,112 $16,000

2.65K

Ticker KLDO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,622,600
Description
Kaleido Biosciences, Inc., a clinical-stage healthcare company, develops microbiome metabolic therapies. The company develops KB195 for the treatment of patients with urea cycle disorder; KB295 to treat ulcerative colitis; KB174 for the treatment of hepatic encephalopathy; and KB109 to treat COVID-19 disease. It also develops programs for the tr...

Get notified when there are updates to the investment portfolio of State Of Wyoming, based on Form 13F filings with the SEC.

Stay updated on State Of Wyoming with notifications on news.